Directorate Change

RNS Number : 7373Y

Dechra Pharmaceuticals PLC

29 January 2014

 

Wednesday, 29 January 2014

Dechra Pharmaceuticals PLC

("Dechra" or the "Company")

Directorate Change

Dechra today announces that following a re-organisation of the Main Board, Ed Torr is to step down as an Executive Director and will be leaving the Company with effect from 31 January 2014.  It is Dechra's intention to enter into a Consultancy Agreement with him later in the year.

Ian Page, Chief Executive Officer of Dechra, said

"On behalf of the Board and colleagues around the business, I would like to thank Ed for the huge contribution he has made to Dechra since joining the business in 1997.  We wish him well for the future."

Enquiries:

Dechra Pharmaceuticals PLC

Ian Page, Chief Executive Officer

Zoe Goulding, Company Secretary

Tel: [phone]

TooleyStreet Communications

Fiona Tooley

Tel: [phone]

email: [e-mail]

About Dechra

Dechra is an international specialist veterinary pharmaceuticals and related products business.  Its expertise is in the development, manufacturing and sales and marketing of high quality products exclusively for veterinarians worldwide.  Dechra's business is unique as the majority of its products are used to treat medical conditions for which there is no other effective solution or have a clinical or dosing advantage over competitor products.

For more information please visit: www.dechra.com

Ticker: LSE Main Listing (Pharmaceuticals): DPH

Trademarks

Dechra and the Dechra "D" logo are registered trademarks of Dechra Pharmaceuticals PLC.

 

END

 

 

BOALLFEALLITFIS